Document is current
Any future updates will be listed below
-
Authors
Ogrinc, Katarina https://orcid.org/0000-0002-8134-749X
Bogovič, Petra
Rojko, Tereza
Maraspin, Vera
Ružić-Sabljić, Eva
Kastrin, Andrej
Strle, Klemen
Wormser, Gary P.
Strle, Franc
-
Funding
Funding for this research was provided by:
University Medical Centre Ljubljana, Slovenia (20220127)
National Institutes of Health (R21AI144916, K01AR062098)
Slovenian Research Agency (P3-0296, J3-1744, J3-8195)
- License Information
-
More Information
Article History
Received: 9 October 2024
Accepted: 20 December 2024
First Online: 2 January 2025
Declarations
:
: The planning, conduct, and reporting of the research in this study are in accordance with the Helsinki Declaration. The study was approved by the Medical Ethics Committee of the Ministry of Health of the Republic of Slovenia (0120–552/2023/3). The Ethics Committee waived the need for written informed consent; however, all patients gave verbal consent for the diagnostic approach routinely employed for suspected LNB, that included CSF examination for which consent was provided orally until 2012, but since 2012 all patients provided written consent for the lumbar puncture.
: G.P.W. reports receiving research grants from Biopeptides, Corp. He has been an expert witness in malpractice cases involving Lyme disease and babesiosis; and is an unpaid board member of the non-profit American Lyme Disease Foundation. K.S. served as a consultant for T2 Biosystems, Roche, BioMerieux, and NYS Biodefense Fund, for the development of a diagnostic assay in Lyme borreliosis. F.S. served on the scientific advisory board for Roche on Lyme disease serological diagnostics and on the scientific advisory board for Pfizer on Lyme disease vaccine, and is an unpaid member of the steering committee of the ESCMID Study Group on Lyme Borreliosis/ESGBOR. Other authors report there are no competing interests to declare.
